Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

specific

A diffuse large B-cell lymphoma that is resistant to treatment.

28

Centers

0

Active Trials

Cancer Funding

Top Centers for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
51.8
2
NCI Comprehensive
51.8
3
NCI Comprehensive
51.8
4
NCI Comprehensive
51.8
5
NCI Comprehensive
51.8
6
NCI Comprehensive
51.8
7
NCI Comprehensive
51.8
851.8
951.8
1051.8
11
NCI Comprehensive
51.8
12
NCI Comprehensive
51.8
13
NCI Comprehensive
51.8
14
NCI Comprehensive
51.8
15
NCI Comprehensive
51.8
1651.8
17
NCI Comprehensive
51.8
1851.8
19
NCI Comprehensive
51.8
2051.8
2151.8
22
NCI Comprehensive
51.8
2351.8
2451.8
2551.8
2651.8
2751.8
28
BC CancerVancouver, BC
51.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →